严重肢体缺血血管内与外科血运重建6个月结局比较
该回顾性、基于人群的队列研究利用全国再入院数据库纳入2016年1月1日至2018年12月31日期间66 277例接受血管内血运重建(ER)或外科血运重建(SR)的严重肢体缺血(CLI)患者,采用倾向评分1:1匹配后得到11 106对匹配。ER与SR相比,6个月大截肢风险高18%(9.9% vs 8.4%;HR 1.18;95%CI 1.08-1.29;P=0.001),但在高容量中心两者大截肢风险无差异。两组死亡率相似(4.7% vs 4.4%;HR 1.06;95%CI 0.93-1.20;P=0.39),ER组院内安全复合结局(急性肾损伤、大出血、血管并发症)风险低17%(23.3% vs 26.8%;OR 0.83;95%CI 0.78-0.88;P<0.001)。作者认为ER更安全、死亡率无差异,但大截肢风险增加,高容量中心两者大截肢风险相似。
要点
- 在倾向评分匹配的11 106对CLI患者中,ER组6个月大截肢风险较SR组高18%(9.9% vs 8.4%;HR 1.18;95%CI 1.08-1.29;P=0.001)。
- 在高容量中心,ER与SR的大截肢风险无差异。
- ER组与SR组6个月死亡率相似(4.7% vs 4.4%;HR 1.06;95%CI 0.93-1.20;P=0.39)。
- ER组院内安全复合结局(急性肾损伤、大出血、血管并发症)风险较SR组低17%(23.3% vs 26.8%;OR 0.83;95%CI 0.78-0.88;P<0.001)。
- 作者认为ER更安全、死亡率无差异,但大截肢风险增加;高容量中心两者大截肢风险相似。
适用人群与场景
- 接受血管内或外科血运重建的严重肢体缺血(CLI)患者,年龄≥18岁,来自全国再入院数据库2016年1月1日至2018年12月31日期间的数据。
- 排除:住院时间信息缺失和/或年龄小于18岁的患者。
研究设计与关键结果
- 研究类型:回顾性、基于人群的队列研究,使用全国再入院数据库,纳入66 277例CLI患者,其中54 546例(82.3%)接受ER,11 731例(17.7%)接受SR;倾向评分1:1匹配后得到11 106对匹配。
- 人群平均(标准差)年龄69.3(12)岁,62.5%为男性。
- 主要终点:ER组6个月大截肢风险较SR组高18%(997/10 090 [9.9%] vs 869/10 318 [8.4%];HR 1.18;95%CI 1.08-1.29;P=0.001)。
- 亚组分析:在高容量中心,ER与SR的大截肢风险无差异。
- 次要终点:ER组与SR组6个月死亡率相似(517/11 106 [4.7%] vs 490/11 106 [4.4%];HR 1.06;95%CI 0.93-1.20;P=0.39)。
- 安全性终点:ER组院内安全复合结局(急性肾损伤、大出血、血管并发症)风险较SR组低17%(2584/11 106 [23.3%] vs 2979/11 106 [26.8%];OR 0.83;95%CI 0.78-0.88;P<0.001)。
证据类型、等级与局限
- 证据类型:回顾性、基于人群的队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,ER更安全、死亡率无差异,但ER与大截肢风险增加相关;在高容量中心两者大截肢风险相似。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: The Bypass Versus Angioplasty for Severe Ischemia of the Leg randomized controlled trial showed comparable outcomes between endovascular revascularization (ER) and surgical revascularization (SR) for patients with critical limb ischemia (CLI). However, several observational studies showed mixed results. Most of these studies were conducted before advanced endovascular technologies were available.
OBJECTIVE: To compare ER and SR treatment strategies for 6-month outcomes among patients with CLI.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective, population-based cohort study used the Nationwide Readmissions Database to identify 66 277 patients with CLI who underwent ER or SR from January 1, 2016, to December 31, 2018. Data analyses were conducted from January 1, 2022, to February 8, 2022. A propensity score with 1:1 matching was applied. Patients with CLI who underwent ER or SR were identified, and those with missing information on the length of stay and/or younger than 18 years were excluded.
EXPOSURES: Endovascular or surgical revascularization.
MAIN OUTCOMES AND MEASURES: The primary outcome was a major amputation at 6 months. Significant secondary outcomes were in-hospital and 6-month mortality and an in-hospital safety composite of acute kidney injury, major bleeding, and vascular complication. Subgroup analysis was conducted for major amputation in high-volume centers.
RESULTS: A total of 66 277 patients were identified between 2016 and 2018 who underwent ER or SR for CLI. The Nationwide Readmissions Database does not provide racial and ethnic categories. The mean (SD) age of the cohort was 69.3 (12) years, and 62.5% of patients were male. A total of 54 546 patients (82.3%) underwent ER and 11 731 (17.7%) underwent SR. After propensity score matching, 11 106 matched pairs were found. Endovascular revascularization was associated with an 18% higher risk of major amputation compared with SR (997 of 10 090 [9.9%] vs 869 of 10 318 [8.4%]; hazard ratio, 1.18; 95% CI, 1.08-1.29; P = .001). However, no difference was observed in major amputation risk when both procedures were performed in high-volume centers. Endovascular revascularization and SR had similar mortality rates (517 of 11 106 [4.7%] vs 490 of 11 106 [4.4%]; hazard ratio, 1.06; 95% CI, 0.93-1.20; P = .39). However, the ER group had a 17% lower risk of in-hospital safety outcomes compared with the SR group (2584 of 11 106 [23.3%] vs 2979 of 11 106 [26.8%]; odds ratio, 0.83; 95% CI, 0.78-0.88; P < .001).
CONCLUSIONS AND RELEVANCE: The results of this study suggest that ER was safer, without any difference in mortality, but ER was associated with an increased risk of major amputation compared with SR. However, the risk of major amputation was similar when both procedures were performed at high-volume centers.
参考来源
- Majmundar M, Patel KN, Doshi R, et al. Comparison of 6-Month Outcomes of Endovascular vs Surgical Revascularization for Patients With Critical Limb Ischemia. JAMA Netw Open. 2022. PMID: 35984655. doi:10.1001/jamanetworkopen.2022.27746
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。